Synchronous Metastatic Hormone-Sensitive Prostate Cancer

1

Review clinical trials related to Synchronous Metastatic Hormone-Sensitive Prostate Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Prospective Prostate Cancer Infrastructure

The goal of this observational study is to collect detailed long-term real-world data and biomaterials from men with high-risk localized prostate cancer and synchronous metastatic hormone-sensitive prostate cancer. This will help to better understand how these patients are treated in daily practice, how treatments affect quality of life, and facilitate biomarker discovery. The infrastructure is also designed to enable future cohort multiple randomized controlled trials.

Participants needed: 700
Trial details
Age: 18+Biological sex: MaleType: ObservationalSponsor: Radboud University Medical CenterUpdated: May 1, 2026Duration: 48 Months
Eligibility criteria

Diagnosis of either: high-risk localized prostate cancer (any of the following:... [+4]

Not currently living in the Netherlands.